Suppr超能文献

药物性维生素缺乏症及其预防(作者译)

[Drug-induced avitaminoses and their prevention (author's transl)].

作者信息

Chiancone F M

出版信息

Acta Vitaminol Enzymol. 1980;2(3-4):75-86.

PMID:7246394
Abstract

The concept of "drug induced avitaminoses" originates from the observation that drugs may cause vitamin deficiencies. These avitaminoses belong to the "iatrogenic disvitaminoses" and can be subdivided into two groups since they may either represent unwanted side effects of a drug or may be utilized for therapeutical purpose. In the latter case they can be considered as "planned avitaminoses". All drugs are generally able to produce a deficiency of one or more vitamins and therefore have a "devitaminizing power". It would be desirable to quantify this property of drugs in terms of a "devitaminization index". Knowledge of this index, which should be acquired for new drugs during clinical research, is of primary importance since it allows to adapt the dosage and use of the drug to the vitaminic status of the patient and enables to foresee and prevent damages due to vitamin deficiency. Drug induced avitaminioses are produced more easily and are more severe if the devitaminizing power of the drug and its dosage are high, the therapy is long and the vitaminic status of the patient is optimal. Many subjects (old people, children, etc.) have an elevated risk of avitaminoses. Drug induced avitaminoses are produced by mechanisms acting both at the intestinal level (absorption, endogenous production, etc.) and at the tissue level (metabolism, utilization, etc.). Some of the mechanisms have not been completely clarified. These avitaminoses are numerous and frequent, but their prevention is relatively easy and always achievable. They constitute a new disease and cause an additional damage with respect to the primary illness. The social and economic aspects of this damage are evident considering that many pharmacological profilactic and therapeutic treatments of social illnesses, such as diabetes, tuberculosis, epilepsy, rheumatic diseases, etc. have a devitaminizing power. It is clear therefore that this pathology is particularly important in preventive medicine and that it must be known not only by practitioners and biologists but also outside the medical field.

摘要

“药物性维生素缺乏症”这一概念源于药物可能导致维生素缺乏的观察结果。这些维生素缺乏症属于“医源性维生素缺乏症”,可分为两组,因为它们要么是药物的不良副作用,要么可用于治疗目的。在后一种情况下,它们可被视为“计划性维生素缺乏症”。所有药物通常都能导致一种或多种维生素缺乏,因此具有“去维生素化能力”。理想的做法是用“去维生素化指数”来量化药物的这一特性。在临床研究中,新药应获取该指数的知识,这至关重要,因为它能使药物的剂量和使用适应患者的维生素状态,并能预见和预防因维生素缺乏造成的损害。如果药物的去维生素化能力及其剂量高、治疗时间长且患者的维生素状态最佳,那么药物性维生素缺乏症更容易发生且更严重。许多人群(老年人、儿童等)患维生素缺乏症的风险较高。药物性维生素缺乏症是由作用于肠道水平(吸收、内源性产生等)和组织水平(代谢、利用等)的机制引起的。其中一些机制尚未完全阐明。这些维生素缺乏症数量众多且常见,但预防相对容易且总是可以实现的。它们构成一种新的疾病,并相对于原发性疾病造成额外损害。考虑到许多社会疾病(如糖尿病、结核病、癫痫、风湿性疾病等)的药理学预防和治疗方法具有去维生素化能力,这种损害的社会和经济方面是显而易见的。因此很明显,这种病理学在预防医学中尤为重要,不仅从业者和生物学家要了解,医学领域之外的人也必须知晓。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验